Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome

Olive, Kenneth P., Tuveson, David A., Ruhe, Zachary C., Yin, Bob, Willis, Nicholas A., Bronson, Roderick T., Crowley, Denise, Jacks, Tyler·2004·Cell

DOI 10.1016/j.cell.2004.11.004

Cited by (1,000)

Items 801–900 of 1,000

Chronic Pancreatitis and Systemic Inflammatory Response Syndrome Prevent Impact of Chemotherapy with Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
Richard Friedemann Knoop, Moritz B. Sparn, Jens Waldmann, Lars Plaßmeier, Detlef Klaus Bartsch, Matthias Lauth, Christoph Hudemann, Volker Fendrich · 2014 · Neoplasia
Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
Dawid Walerych, Magdalena Pruszko, Lukasz Zyla, Michalina Wężyk, Katarzyna Gawęda-Walerych, Maciej Żylicz · 2018 · Oncotarget
Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness
Maciej B. Olszewski, Magdalena Pruszko, Ewa B. Snaar-Jagalska, Maciej Żylicz, Maciej Żylicz · 2019 · International Journal of Oncology
Emerging treatment options for patients with p53-pathway-deficient CLL
Marisa J.L. Aitken, Hun Ju Lee, Sean M. Post · 2019 · Therapeutic Advances in Hematology
Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers
May San Martinho, Derek J. Nancarrow, Theodore Steven Lawrence, David G. Beer, Dipankar Ray · 2020 · Cellular and Molecular Gastroenterology and Hepatology
Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?
Felicia Leccia, Marie Batisse‐Lignier, Isabelle Sahut‐Barnola, Pierre Val, Anne‐Marie Lefrançois‐Martinez, Antoine Martinez · 2016 · Frontiers in Endocrinology
Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
Evguenia M. Alexandrova, Sulan Xu, Ute Martha Moll · 2017 · Cell Death and Disease
Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancer
Lars Plaßmeier, Richard Friedemann Knoop, Jens Waldmann, Rebecca Kesselring, Malte Buchholz, Stefan Fichtner‐Feigl, Detlef Klaus Bartsch, Volker Fendrich · 2013 · Langenbeck s Archives of Surgery
Practical Use of Advanced Mouse Models for Lung Cancer
Roghaiyeh Safari, Ralph Leo Johan Meuwissen · 2015 · Methods in molecular biology
Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations
Roland Imle, Felix K. F. Kommoss, Ana Banito · 2021 · Journal of Clinical Medicine
Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
Mayra A. Marques, Guilherme Caldas de Andrade, Jerson Lima Silva, Guilherme A. P. de Oliveira · 2022 · Frontiers in Molecular Biosciences
Prevalence, causes and impact of TP53-loss phenocopying events in human tumors
Bruno Fito-Lopez, Marina Salvadores, Miguel M. Álvarez‐Álvarez, Fran Supek · 2023 · BMC Biology
Genetic and functional analysis of a Li Fraumeni syndrome family in China
Huaying Hu, Jingping Liu, Xinbin Liao, Shuju Zhang, Haibo Li, Renbin Lu, Xianfeng Li, Lin Wei, Minji Liu, Zanxian Xia et al. · 2016 · Scientific Reports
The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer
Callum Hall, Patricia A. J. Muller · 2019 · International Journal of Molecular Sciences
Keap1 deletion accelerates mutant K-ras/p53-driven cholangiocarcinoma
Tatsuhide Nabeshima, Shin Hamada, Keiko Taguchi, Yu Tanaka, Ryotaro Matsumoto, Masayuki P. Yamamoto, Atsushi Masamune · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Rb and p53 Execute Distinct Roles in the Development of Pancreatic Neuroendocrine Tumors
Yuki Yamauchi, Yuzo Kodama, Masahiro Shiokawa, Nobuyuki Kakiuchi, Saiko Marui, Takeshi Kuwada, Yuko Sogabe, Teruko Tomono, Atsushi Mima, Toshihiro Morita et al. · 2020 · Cancer Research
Hes1 Is Essential in Proliferating Ductal Cell–Mediated Development of Intrahepatic Cholangiocarcinoma
Tomoaki Matsumori, Yuzo Kodama, Atsushi Takai, Masahiro Shiokawa, Yoshihiro Nishikawa, Tomonori Matsumoto, Haruhiko Takeda, Saiko Marui, Hirokazu Okada, Tomonori Hirano et al. · 2020 · Cancer Research
Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells
Amr M. Ghaleb, Malik Padellan, Natalia D. Marchenko · 2020 · Breast Cancer Research
Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li‐Fraumeni or Li‐Fraumeni‐like syndrome
Waka Sugawara, Yasuhito Arai, Fumio Kasai, Yuiko Fujiwara, Masayuki Haruta, Rie Hosaka, 一典西田, 黒住昌史, Yasuhito Kobayashi, Kiwamu Akagi et al. · 2011 · Genes Chromosomes and Cancer
Mutation at Ser392 specifically sensitizes mutant p53H175 to mdm2-mediated degradation
Sébastien Gillotin, Damian Yap, Xin Lü · 2010 · Cell Cycle
Transcription activity is required for p53-dependent tumor suppression
Olga Gaidarenko, Yang Xu · 2009 · Oncogene
Does a p53 “Wild-type” Immunophenotype Exclude a Diagnosis of Endometrial Serous Carcinoma?
Oluwole Fadare, Andres A. Roma, Vinita Parkash, Wenxin Zheng, Vighnesh Walavalkar · 2017 · Advances in Anatomic Pathology
Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs
Weili Ma, Yunping Lin, Wanli Xuan, Patrick L. Iversen, L J Smith, Samuel Benchimol · 2011 · Oncogene
ELF3 suppresses gallbladder cancer development through downregulation of the EREG / EGFR / mTOR complex 1 signalling pathway
Takeharu Nakamura, Yoshihiro Nishikawa, Masahiro Shiokawa, Haruhiko Takeda, Masataka Yokode, Shimpei Matsumoto, Yuya Muramoto, Sakiko Ota, Hiroyuki Yoshida, Hirokazu Okada et al. · 2023 · The Journal of Pathology
Acid-base homeostasis orchestrated by NHE1 defines the pancreatic stellate cell phenotype in pancreatic cancer
Zoltán Pethő, Karolina Najder, Stephanie Beel, Benedikt Fels, Ilka Neumann, Sandra Schimmelpfennig, Sarah Sargin, Maria Wolters, Klavs Grantins, Eva Wardelmann et al. · 2023 · JCI Insight
Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants
Anasuya Pal, Laura G. Gonzalez-Malerva, Seron Eaton, Chenxi Xu, Yining Zhang, Dustin Grief, Lydia Sakala, Lilian Nwekwo, Jia Zeng, Grant Christensen et al. · 2023 · npj Breast Cancer
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions
Marco Cordani, Alessia Garufi, Rossella Benedetti, Marco Tafani, Michele Aventaggiato, Gabriella D’Orazi, Mara Cirone · 2024 · Biomolecules
Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD)
Hamish G. Campbell, Reena Mehta, Axel A. Neumann, Carlos Rubio‐Terres, Margaret A. Baird, Tania L. Slatter, Antony W. Braithwaite · 2012 · Oncogene
p53 missense mutant G242A subverts natural killer cells in sheltering mouse breast cancer cells against immune rejection
Mohammad B. Uddin, Kartik R. Roy, Ronald A. Hill, Sagor Chandra Roy, Xin Gu, Li Li, Qian-Jin Zhang, Zongbing You, Yu Liu · 2022 · Experimental Cell Research
Polyploidization and Cancer
Randy Y.C. Poon · 2010 · Advances in experimental medicine and biology
Chromosome instability and carcinogenesis: Insights from murine models of human pancreatic cancer associated with BRCA2 inactivation
Liam D. Cassidy, Siong‐Seng Liau, Ashok R. Venkitaraman · 2013 · Molecular Oncology
Transposon-mediated mutagenesis of somatic cells in the mouse for cancer gene identification
David A. Largaespada · 2009 · Methods
Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex
Pavla Brachova, Samuel R. Mueting, Eric Jeffrey Devor, Kimberly Kay Leslie · 2014 · Journal of Cancer Therapy
Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line
Philipp Schröter, Laura Hartmann, Wolfram Osen, Daniel Baumann, Rienk Offringa, David Eisel, Jürgen Debus, Stefan B. Eichmüller, Stefan Rieken · 2020 · Scientific Reports
What do we need to know and understand about p53 to improve its clinical value?
Salomao, Norman, Karakostis, Konstantinos, Hupp, Ted, Vollrath, Friz, Vojtesek, Borivoj, Fahraeus, Robin · 2021 · The Journal of Pathology
Genomic landscape and preclinical models of angiosarcoma
Annaleigh Benton, Bozhi Liu, Lauren E. Gartenhaus, Jason A. Hanna · 2024 · Molecular Oncology
Activation of S6 signaling is associated with cell survival and multinucleation in hyperplastic skin after epidermal loss of AURORA-A Kinase
Weston Kenneth Ryan, Josiah Fernandez, Mikayla Katherine Peterson, David William Sheneman, Brendan K. Podell, Subhajyoti De, Enrique C. Torchia · 2018 · Cell Death and Differentiation
A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice
Adhithi Rajagopalan, Yubin Feng, Meher Bolisetti Gayatri, Erik A. Ranheim, Taylor Klungness, Daniel R. Matson, Moon Hee Lee, Mabel Minji Jung, Yun Zhou, Xin Gao et al. · 2023 · Journal of Clinical Investigation
p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett’s oesophagus
Guodong Lian, Ermanno Malagola, Chengguo Wei, Qiongyu Shi, Junfei Zhao, Masahiro Hata, Hiroki Kobayashi, Yosuke Ochiai, Biyun Zheng, Xiaofei Zhi et al. · 2024 · Gut
Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic Strategy
Fatima I. AlMaazmi, Lara J. Bou Malhab, Leen Eldohaji, Maha Mohamed Saber-Ayad · 2025 · Cells
p53 Mutation in the Genesis of Metastasis
William Andrew Yeudall · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
Rapamycin impairs UV induction of mutant‐p53 overexpressing cell clusters without affecting tumor onset
Pieter Voskamp, C.A. Bodmann, Heggert G Rebel, Gudrun E. Koehl, Cornelis P. Tensen, Jan Nico Bouwes Bavinck, Abdoelwaheb El Ghalbzouri, Henk J. van Kranen, Rein Willemze, Edward Kenneth Geissler et al. · 2011 · International Journal of Cancer
p53 codon 271 CGT to CAT mutant fraction does not increase in nasal respiratory and olfactory epithelia of rats exposed to inhaled naphthalene
Fanxue Meng, Yiying Wang, Meagan B. Myers, Brian A. Wong, Elizabeth A. Gross, Harvey J. Clewell III M.A., Darol E. Dodd, Barbara L. Parsons · 2011 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis
Ryan L. Hanson, Roger B. Brown, Maria M. Steele, Paul M. Grandgenett, James A. Grunkemeyer, Michael Anthony Hollingsworth · 2016 · Oncotarget
Anticancer potential of benzothiazolic derivative (E)-2-((2-(benzo[d]thiazol-2-yl)hydrazono)methyl)-4-nitrophenol against melanoma cells
Zanair Soares Vasconcelos, Ana Carolina Lima Ralph, Danielle Queiroz Calcagno, Gleyce dos Santos Barbosa, Tatiana do Nascimento Pedrosa, Lucas Pio Antony, Marı́lia de Arruda Cardoso Smith, Eliza de Lucas Chazin, T.R.A. Vasconcelos, Raquel Carvalho Montenegro et al. · 2018 · Toxicology in Vitro
RET, a targetable driver of pancreatic adenocarcinoma
Moran Amit, Shorook Na’ara, Eran Fridman, Euvgeni Vladovski, Tanya Wasserman, Neta Milman, Ziv Gil · 2018 · International Journal of Cancer
Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?
Eziafa Oduah, Steven R. Grossman · 2020 · Cancer Biology & Therapy
The Janus Face of p53-Targeting Ubiquitin Ligases
Qian Hao, Yajie Chen, Xiang Yu Zhou · 2020 · Cells
p73 isoforms meet evolution of metastasis
Stella Logotheti, Athanasia Pavlopoulou, Stephan Marquardt, Işıl Takan, Alexandros G. Georgakilas, Thorsten Stiewe · 2022 · Cancer and Metastasis Reviews
Involvement of p53 Mutation and Mismatch Repair Proteins Dysregulation in NNK-Induced Malignant Transformation of Human Bronchial Epithelial Cells
Ying Shen, Shuilian Zhang, Xiaobin Huang, Kailin Chen, Jing Shen, Zhengyang Wang · 2014 · BioMed Research International
Hereditary cancer syndromes as model systems for chemopreventive agent development
Farzana L. Walcott, Jigar Patel, Ronald A. Lubet, Luz M. Rodriguez, Kathleen A. Calzone · 2015 · Seminars in Oncology
TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response
Nagako Akeno, Alisa L. Reece, Melissa K. Callahan, Ashley L. Miller, Rebecca G. Kim, Diana He, Adam Lane, Jonathan S. Moulton, Kathryn A. Wikenheiser‐Brokamp · 2017 · Molecular Cancer Therapeutics
Down‐regulation of dishevelled‐2 inhibits cell proliferation and invasion in hepatoblastoma
Siqi Huang, Jing Chen, Ruicheng Tian, Jing Wang, Chenjie Xie, Hongxiang Gao, Yuhua Shan, Jie Hong, Zhen Zhang, Min Xu et al. · 2018 · Pediatric Blood & Cancer
Mutant p53R175H promotes cancer initiation in the pancreas by stabilizing HSP70
Kishore Polireddy, Kanchan Singh, Melissa A. Pruski, Neal C. Jones, Naveen V. Manisundaram, Pavani Ponnela, Michel M. Ouellette, George Van Buren, Mamoun Younes, John S. Bynon et al. · 2019 · Cancer Letters
Genetic drivers and cells of origin in sarcomagenesis
Sarmishta Kannan, Ian C. Lock, Benjamin B. Ozenberger, Kevin B. Jones · 2021 · The Journal of Pathology
Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling
Franziska Wachter, M Grunert, Cristina Blaj, David M. Weinstock, Irmela Jeremias, Harald Ehrhardt · 2013 · Cell Communication and Signaling
Metal-Based Anticancer Complexes and p53: How Much Do We Know?
Samah Mutasim Alfadul, Egor M. Matnurov, Alexander E. Varakutin, Maria V. Babak · 2023 · Cancers
Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissues
Pengle Yao, Peng Xiao, Zongyao Huang, Min Tang, Xiwen Tang, Gaoxia Yang, Qi Zhang, Xinpei Li, Zhengnan Yang, Chuanxing Xie et al. · 2023 · Nature Cancer
Selective metabolic regulations by p53 mutant variants in pancreatic cancer
Sabrina Caporali, Alessio Butera, Alessia Ruzza, Carlotta Zampieri, Marina Bantulà, Sandra Scharsich, Anna‐Katharina Ückert, Ivana Celardo, Ivan U. Kouzel, Luigi Leanza et al. · 2024 · Journal of Experimental & Clinical Cancer Research
In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2′-deoxy-2′-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models
James Russell, Nagavarakishore Pillarsetty, Robin M. Kramer, Paul Bernard Romesser, Pooja Desai, Adriana Haimovitz‐Friedman, Maeve Aine Lowery, John Laurence Humm · 2017 · Molecular Imaging and Biology
Runx3 and Cell Fate Decisions in Pancreas Cancer
Martin C. Whittle, Sunil R. Hingorani · 2017 · Advances in experimental medicine and biology
Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis
Vladimir N. Babenko, Malay Kumar Basu, Fyodor A. Kondrashov, Igor B. Rogozin, Eugene V. Koonin · 2006 · BMC Cancer
Chromosomal instability in mouse metastatic pancreatic cancer—it’s Kras and Tp53 after all
Jens Thomas Siveke, Roland Michael Schmid · 2005 · Cancer Cell
Spontaneous Genomic Alterations in a Chimeric Model of Colorectal Cancer Enable Metastasis and Guide Effective Combinatorial Therapy
Yinghui Zhou, William M. Rideout, Angela Bressel, Sireesha Yalavarthi, Tong Zi, Darren Potz, Samuel J. Farlow, Joelle Brodeur, Anthony Monti, Shailaja Reddipalli et al. · 2014 · PLoS ONE
p53 Pathway Alterations in Brain Tumors
Shaoman Yin, Erwin G. Van Meir · 2009 · Humana Press eBooks
LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer
Li-Xiang Ma, H. Saiyin · 2017 · PLoS ONE
Off and back-on again: a tumor suppressor’s tale
Jonuelle Acosta, Walter Wang, David M. Feldser · 2018 · Oncogene
p53: not just a tumor suppressor
Moshe Oren · 2019 · Journal of Molecular Cell Biology
Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis
Yanhong Zhang, Xiuli Feng, Jin Zhang, Minyi Chen, Eric C. Huang, Xinbin Chen · 2019 · Oncogene
Genetic signature for human risk assessment: Lessons from trichloroethylene
Yih‐Horng Shiao · 2008 · Environmental and Molecular Mutagenesis
Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma
Katherine Minjee Chung, Jaffarguriqbal Singh, Lauren Lawres, Kimberly Judith Dorans, Cathy C. Garcia, Daniel B. Burkhardt, Rebecca Robbins, Arjun J. Bhutkar, REBECCA L. CARDONE, Xiaojian Zhao et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
In‐frame deletion of SMC5 related with the phenotype of primordial dwarfism, chromosomal instability and insulin resistance
Wenjiao Zhu, Yuanping Shi, Chang-Run Zhang, Yajie Peng, Yueyue Wan, Yue Xu, Xuemeng Liu, Bing Han, Shuang‐Xia Zhao, Yanping Kuang et al. · 2023 · Clinical and Translational Medicine
FRA1 controls acinar cell plasticity during murine KrasG12D induced pancreatic acinar to ductal metaplasia
Alina L. Li, Kensuke Sugiura, Noriyuki Nishiwaki, Kensuke Suzuki, Dorsay Sadeghian, Jun Zhao, A. Maitra, David Falvo, R. Chandwani, Jason R. Pitarresi et al. · 2024 · Developmental Cell
KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling
Emily L. Lasse Opsahl, Ivana Barravecchia, Elyse McLintock, Jennifer M. Lee, Sarah F. Ferris, Carlos E. Espinoza, Rachael Hinshaw, Sophia Cavanaugh, Marzia Robotti, Lily Rober et al. · 2025 · JCI Insight
Development of a Mouse Model of Menopausal Ovarian Cancer
Elizabeth R. Smith, Ying Wang, Xiang‐Xi Xu · 2014 · Frontiers in Oncology
Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α
Robert D. Kendig, Fumitake Kai, Elizabeth A. Fry, Kazushi Inoue · 2017 · Cancer Investigation
DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2
Shilpa Singh, Catherine A. Vaughan, Christopher S. Rabender, Ross B. Mikkelsen, Sumitra Deb, Swati Palit Deb · 2019 · JCI Insight
Comprehensive Detection of Single Amino Acid Variants and Evaluation of Their Deleterious Potential in a PANC-1 Cell Line
Zhijing Tan, Jianhui Zhu, Paul M. Stemmer, Liangliang Sun, Zhichang Yang, Kendall Schultz, Matthew J. Gaffrey, Anthony J. Cesnik, Xinpei Yi, Xiaohu Hao et al. · 2020 · Journal of Proteome Research
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
Matteo Canale, Elisabetta Petracci, Paola Cravero, Marita Mariotti, Gabriele Minuti, Giulio Metro, Vienna Ludovini, Sara Baglivo, Maurizio Puccetti, Alessandra Dubini et al. · 2022 · Translational Oncology
Gain-of-functionc-CBLmutations associated with uniparental disomy of 11q in myeloid neoplasms
Seishi Ogawa, Masashi Sanada, Lee-Young Shih, Takahiro Suzuki, Makoto Otsu, Hiromitsu Nakauchi, H. Phillip Koeffler · 2010 · Cell Cycle
Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models
Daniel L.J. Thorek, Robin M. Kramer, Qing Chen, Jeho Jeong, Mihaela E. Lupu, Alycia M. Lee, Mary Ellen Moynahan, Maeve Aine Lowery, David Ulmert, PAT B. ZANZONICO et al. · 2015 · International Journal of Radiation Oncology*Biology*Physics
The dichotomy of p53 regulation by noncoding RNAs
Qipan Deng, L. Becker, Xiaodong Ma, Xiao‐bo Zhong, Ken H. Young, Kenneth S. Ramos, Y. Li · 2014 · Journal of Molecular Cell Biology
Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
Amr M. Ghaleb, Alisha R. Yallowitz, Natalia D. Marchenko · 2019 · Communications Biology
Expression of a Mutant p53 Results in an Age-Related Demographic Shift in Spontaneous Lung Tumor Formation in Transgenic Mice
Wenrui Duan, Li Gao, Xin Wu, Erinn M. Hade, Jianxin Gao, Haiming Ding, Sanford H. Barsky, Gregory A. Otterson, Miguel Angel Villalona-Calero · 2009 · PLoS ONE
Using Genetically Engineered Mice for Radiation Research
David G. Kirsch · 2011 · Radiation Research
Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment
Ryosuke Kashiwagi, Ryo Funayama, Shuichi Aoki, Aya Matsui, Sebastian Klein, Yukihiro Sato, Tsubasa Suzuki, Keigo Murakami, Koetsu Inoue, Masahiro Iseki et al. · 2023 · Cancer Science
Mutant p53 in Cell Adhesion and Motility
William Andrew Yeudall, Katharine H. Wrighton, Sumitra Deb · 2012 · Methods in molecular biology
A Platform for Validating Colorectal Cancer Driver Genes Using Mouse Organoids
Haruna Takeda · 2021 · Frontiers in Genetics
TP53 Modulates Oxidative Stress in Gata1 + Erythroid Cells
Ashley C. Kramer, Jenna M. Weber, Ying Zhang, Jakub Tolar, Ying Gibbens, Margaret E. Shevik, Troy C. Lund · 2017 · Stem Cell Reports
Transcriptional Landscape of PARs in Epithelial Malignancies
Jeetendra Kumar Nag, Rachel Bar‐Shavit · 2018 · International Journal of Molecular Sciences
p53, A Victim of the Prion Fashion
Olivier Billant, Gaëlle Friocourt, Pierre Roux, Cécile Voisset · 2021 · Cancers
Identification of cancer driver genes using Sleeping Beauty transposon mutagenesis
Haruna Takeda, Nancy A. Jenkins, Neal G. Copeland · 2021 · Cancer Science
Comprehensive omics studies of p53 mutants in human cancer
Lakshay Malhotra, Alankrita Singh, Punit Kaur, Abdul Samath Ethayathulla · 2022 · Briefings in Functional Genomics
Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53
Douglas W. Brown, Perrin H. Beatty, John D. Lewis · 2022 · Cancers
Characteristics and survival of patients with advanced cancer and p53 mutations
Rabih Said, Yang Ye, David S. Hong, Filip Jankú, Siqing Fu, Aung Naing, Jennifer J. Wheler, Razelle Kurzrock, Christoforos G. Thomas, Gary A. Palmer et al. · 2014 · Oncotarget
Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor Profiles
Carrie R. Graveel, Jack D. DeGroot, Robert E. Sigler, George F. Vande Woude · 2010 · PLoS ONE
Genetically Engineered Knock-In and Conditional Knock-In Mouse Models of Cancer
Amy Rappaport, Leisa Johnson · 2014 · Cold Spring Harbor Protocols
Deciphering TP53 mutant Cancer Evolution with Single-Cell Multi-Omics
Alba Rodríguez-Meira, Ruggiero Norfo, Wei Xiong Wen, Agathe L. Chédeville, Haseeb Rahman, Jennifer O’Sullivan, Guanlin Wang, Eleni Louka, Warren W. Kretzschmar, Aimee Paterson et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Mutant p53: evolving perspectives
Gizem Efe, Katherine M. Cunningham, Anil K. Rustgi, Carol L. Prives, James J. Manfredi, Francisco J. Sánchez Rivera · 2025 · Genes & Development
TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer
Shonosuke Wakayama, Kota Ouchi, Shinʼ ichi Takahashi, Yasuhide Yamada, Yoshito Komatsu, Ken Shimada, Tatsuro Yamaguchi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka · 2023 · Clinical Colorectal Cancer